Muutke küpsiste eelistusi

WHO list of priority medical devices for cancer management Web Edition [Pehme köide]

  • Formaat: Paperback / softback, 246 pages, kaal: 815 g
  • Ilmumisaeg: 08-May-2017
  • Kirjastus: World Health Organization
  • ISBN-10: 9241565462
  • ISBN-13: 9789241565462
Teised raamatud teemal:
  • Formaat: Paperback / softback, 246 pages, kaal: 815 g
  • Ilmumisaeg: 08-May-2017
  • Kirjastus: World Health Organization
  • ISBN-10: 9241565462
  • ISBN-13: 9789241565462
Teised raamatud teemal:
This is the model list and clearing house of appropriate, basic, and priority medical devices based on the list of clinical interventions selected from clinical guidelines on prevention, screening, diagnosis, treatment, palliative care, monitoring, and end of life care. This publication addresses medical devices that can be used for the management of cancer and specifically describes medical devices for six types of cancer: breast, cervical, colorectal, leukemia, lung, and prostate.

This book is intended for ministries of health, public health planners, health technology managers, disease management, researchers, policy makers, funding, and procurement agencies and support and advocacy groups for cancer patients.
Acknowledgements
Navigation diagram
4(1)
Acronyms and abbreviations
5(1)
Cancer colour codes
6(1)
Executive summary
7(1)
I Background
8(8)
I.I WHO leadership priorities: increasing access to medical products
8(1)
I.II WHO resolution on health technologies
8(1)
I.III UN declaration and action plan for noncommunicable diseases
9(1)
I.IV The burden of cancer
9(2)
I.V Availability of specific medical devices for cancer
11(5)
II Methodology
16(6)
III Priority medical devices by clinical areas
22(128)
1 Vaccination, clinical assessment & endoscopy
26(12)
1.1 General description of the unit
28(1)
1.2 Priority medical devices for vaccination
28(1)
1.2.1 Specific medical devices for vaccination
28(1)
1.3 Priority medical devices for clinical assessment
29(5)
1.3.1 General medical devices for clinical assessment
30(1)
1.3.2 Specific medical devices for clinical assessment and minor procedures by cancer type
31(3)
1.4 Priority medical devices for endoscopy
34(3)
1.4.1 General medical devices for endoscopy
34(2)
1.4.2 Specific medical devices for endoscopy by cancer type
36(1)
1.4.3 Guidance documents
37(1)
1.5 Human resources for clinical assessment
37(1)
2 Medical imaging & nuclear medicine
38(30)
2.1 General description of the medical imaging unit
40(1)
2.2 Priority medical devices for medical imaging
40(9)
2.2.1 General medical devices for medical imaging
41(5)
2.2.2 Specific medical devices for medical imaging by cancer type
46(3)
2.3 Other health system components for medical imaging
49(7)
2.3.1 Human resources for medical imaging
49(1)
2.3.2 Infrastructure
50(1)
2.3.3 Quality management
51(1)
2.3.4 Guidance documents
52(4)
2.4 General description of the nuclear medicine unit
56(1)
2.5 Priority medical devices for nuclear medicine
56(5)
2.5.1 General medical devices for nuclear medicine
57(3)
2.5.2 Specific medical devices for nuclear medicine by cancer type
60(1)
2.6 Other health system components for nuclear medicine
61(7)
2.6.1 Human resources for nuclear medicine
61(1)
2.6.2 Infrastructure
62(2)
2.6.3 Quality management
64(1)
2.6.4 Guidance documents
64(4)
3 Surgery
68(20)
3.1 General description of the unit
70(1)
3.2 Priority medical devices for surgery
70(13)
3.2.1 General medical devices for surgery
71(4)
3.2.2 Specific medical devices for surgery by cancer type
75(2)
3.2.3 Surgical instrument sets, catheter and needle sizes
77(6)
3.3 Other health system components
83(5)
3.3.1 Human resources for surgery
83(1)
3.3.2 Infrastructure
84(1)
3.3.3 Quality management
85(1)
3.3.4 Guidance documents
86(2)
4 Clinical laboratory & pathology
88(22)
4.1 General description of the unit
90(1)
4.2 Priority medical devices for clinical laboratory
90(9)
4.2.1 General medical devices for clinical laboratory
91(6)
4.2.2 Specific medical devices for clinical laboratory by cancer type
97(2)
4.3 Priority medical devices for pathology
99(6)
4.3.1 General medical devices for pathology
99(1)
4.3.2 General medical devices for histopathology
100(3)
4.3.4 General medical devices for immunohistochemistry
103(1)
4.3.5 Special stain (histochemical)
104(1)
4.4 Other health system components
105(5)
4.4.1 Human resources for clinical laboratory and anatomic pathology
105(1)
4.4.2 Infrastructure
105(2)
4.4.3 Quality management
107(2)
4.4.4 Guidance documents
109(1)
5 Radiotherapy
110(18)
5.1 General description of the unit
112(1)
5.2 Priority medical devices
112(6)
5.2.1 General medical devices for external radiotherapy
112(3)
5.2.2 General medical devices for brachytherapy
115(3)
5.2.3 Specific medical devices for brachytherapy by cancer type
118(1)
5.3 Other health system components
118(10)
5.3.1 Human resources for radiotherapy
118(2)
5.3.2 Infrastructure
120(2)
5.3.3 Quality management
122(2)
5.3.4 Guidance documents
124(4)
6 Systemic therapy
128(12)
6.1 General description of the unit
130(1)
6.2 Priority medical devices
130(4)
6.2.1 General medical devices for systemic therapy
131(3)
6.2.2 Specific medical devices for systemic therapy by cancer type
134(1)
6.3 Other health system components
134(6)
6.3.1 Human resources for systemic therapy
134(1)
6.3.2 Infrastructure
135(2)
6.3.3 Quality management
137(1)
6.3.4 Guidance documents
138(2)
7 Palliative care & end of life care
140(10)
7.1 General description of the unit
142(1)
7.1.1 Definition
142(1)
7.1.2 Purposes
142(1)
7.1.3 Palliative treatment
142(1)
7.2 Priority medical devices
142(5)
7.2.1 General medical devices for palliative care and end of life care
143(3)
7.2.2 Specific medical devices for palliative care and end of life care by cancer type
146(1)
7.3 Other health system components
147(3)
7.3.1 Human resources for palliative care and end of life care
147(1)
7.3.2 Infrastructure
148(1)
7.3.3 Quality management
149(1)
IV Implementation strategy
150(6)
IV.I Approach for adapting the WHO list of priority medical devices for cancer management in each setting
150(4)
IV.II Future activities
154(1)
IV.III Concluding Remarks
155(1)
Glossary 156(4)
Annex 1 Clinical interventions 160(58)
Annex 2 Experts information 218(8)
Annex 3 Terms of reference for experts groups 226(8)
Annex 4 List of priority medical devices for cancer 234